JPWO2022159871A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022159871A5 JPWO2022159871A5 JP2023544528A JP2023544528A JPWO2022159871A5 JP WO2022159871 A5 JPWO2022159871 A5 JP WO2022159871A5 JP 2023544528 A JP2023544528 A JP 2023544528A JP 2023544528 A JP2023544528 A JP 2023544528A JP WO2022159871 A5 JPWO2022159871 A5 JP WO2022159871A5
- Authority
- JP
- Japan
- Prior art keywords
- neuron
- composition
- ligand
- seq
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163141124P | 2021-01-25 | 2021-01-25 | |
| US202163141121P | 2021-01-25 | 2021-01-25 | |
| US63/141,124 | 2021-01-25 | ||
| US63/141,121 | 2021-01-25 | ||
| US202163285929P | 2021-12-03 | 2021-12-03 | |
| US63/285,929 | 2021-12-03 | ||
| PCT/US2022/013658 WO2022159871A1 (en) | 2021-01-25 | 2022-01-25 | Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024505197A JP2024505197A (ja) | 2024-02-05 |
| JP2024505197A5 JP2024505197A5 (https=) | 2025-02-03 |
| JPWO2022159871A5 true JPWO2022159871A5 (https=) | 2025-02-03 |
Family
ID=82549286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544528A Pending JP2024505197A (ja) | 2021-01-25 | 2022-01-25 | 焦点てんかんおよび神経因性疼痛を処置するためのアデノ随伴ウイルスカプシドおよび操作されたリガンド依存性イオンチャネル |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240108760A1 (https=) |
| EP (1) | EP4281551A4 (https=) |
| JP (1) | JP2024505197A (https=) |
| KR (1) | KR20230149299A (https=) |
| AU (1) | AU2022211055A1 (https=) |
| CA (1) | CA3205877A1 (https=) |
| IL (1) | IL304511A (https=) |
| MX (1) | MX2023008738A (https=) |
| WO (1) | WO2022159871A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025188847A1 (en) * | 2024-03-07 | 2025-09-12 | The Texas A&M University System | Method for treating epilepsy |
| WO2025230969A1 (en) * | 2024-05-02 | 2025-11-06 | 4D Molecular Therapeutics Inc. | Aav variants with improved cns tropism and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1856576B (zh) * | 2003-09-30 | 2011-05-04 | 宾夕法尼亚州立大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| WO2015126972A1 (en) * | 2014-02-21 | 2015-08-27 | University Of Florida Research Foundation, Inc. | Methods and compositions for gene delivery to on bipolar cells |
| AU2016324317A1 (en) * | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| EP3468545A4 (en) * | 2016-06-08 | 2020-07-22 | President and Fellows of Harvard College | METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, RETT SYNDROME AND FRAGILE X SYNDROME |
| MX2020005470A (es) * | 2017-11-27 | 2020-11-09 | Coda Biotherapeutics Inc | Composiciones y metodos para enfermedades neurologicas. |
| US20210261962A1 (en) * | 2018-06-21 | 2021-08-26 | The Board Of Regents Of The University Of Texas System | Correction of dystrophin exon 43, exon 45, or exon 52 deletions in duchenne muscular dystrophy |
-
2022
- 2022-01-25 KR KR1020237028925A patent/KR20230149299A/ko active Pending
- 2022-01-25 AU AU2022211055A patent/AU2022211055A1/en active Pending
- 2022-01-25 MX MX2023008738A patent/MX2023008738A/es unknown
- 2022-01-25 CA CA3205877A patent/CA3205877A1/en active Pending
- 2022-01-25 EP EP22743368.7A patent/EP4281551A4/en active Pending
- 2022-01-25 WO PCT/US2022/013658 patent/WO2022159871A1/en not_active Ceased
- 2022-01-25 JP JP2023544528A patent/JP2024505197A/ja active Pending
- 2022-01-25 US US18/273,867 patent/US20240108760A1/en active Pending
-
2023
- 2023-07-17 IL IL304511A patent/IL304511A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022141670A5 (https=) | ||
| JP2018508519A5 (https=) | ||
| IL278213B1 (en) | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) | |
| WO2023060269A4 (en) | Recombinant adeno-associated viruses for targeted delivery | |
| JP2021525245A5 (https=) | ||
| JP2021533805A5 (https=) | ||
| RU2018145010A (ru) | Оптимизированные гены и экспрессионные кассеты cln1, и их применение | |
| RU2018132517A (ru) | Aav-idua вектор для лечения ассоциированной с mps i слепоты | |
| JP2021500922A5 (https=) | ||
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| JP2020519629A5 (https=) | ||
| IL300294A (en) | Gene therapy using nucleic acid constructs containing methyl CPG-binding protein 2 (MECP2) promoter sequences | |
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| MX2023012410A (es) | Metodos para tratar enfermedades oculares usando variantes de aav2 que codifican aflibercept. | |
| JPWO2022053630A5 (https=) | ||
| CN121219325A (zh) | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 | |
| JPWO2022159871A5 (https=) | ||
| JPWO2021050614A5 (https=) | ||
| JPWO2018102665A5 (https=) | ||
| JPWO2022034130A5 (https=) | ||
| JPWO2020242892A5 (https=) | ||
| JPWO2023147604A5 (https=) | ||
| JPWO2020072677A5 (https=) | ||
| JPWO2020237130A5 (https=) | ||
| JP2020531047A5 (https=) |